论文部分内容阅读
临床资料 1 一般资料 63例肾综合征出血热(HFRS)病例均符合卫生部1987年颁发的《流行性出血热防治方案》制定的诊断标准,且属于发病4d内单纯发热期患者。随机分为治疗组33例,对照组30例。全部病例经血清学检查HFRS荧光抗体均呈阳性结果。两组在性别、年龄、入院时病情及实验室结果具有可比性(P>0.05)。 2 治疗方法 两组均应用病毒唑500～700mg/d加入10％葡萄糖溶液500ml中分2次静滴,共5d,治疗组在上述治疗基础上应用氢化可的松100～200mg/d加入5％葡萄糖溶液
Clinical data 1 General information 63 cases of hemorrhagic fever with renal syndrome (HFRS) cases are in line with the “epidemic hemorrhagic fever prevention and treatment program” issued by the Ministry of Health in 1987 to develop diagnostic criteria, and are within 4d onset of fever in patients with simple. Randomly divided into treatment group 33 cases, control group 30 cases. All cases were positive by serological test HFRS fluorescent antibody. The two groups were comparable in gender, age, admission and laboratory results (P> 0.05). 2 treatment of both groups were treated with ribavirin 500 ~ 700mg / d 10% glucose solution 500ml two intravenous infusion, a total of 5d, the treatment group based on the above treatment with hydrocortisone 100 ~ 200mg / d by adding 5% Glucose solution